CD53 and neoplasm: Taken together and from a disease perspective, tumor initiating potential of CD53 expressing CSCs and progenitors could define tumor dormancy and recurrent disease, while aneuploid cells are likely to contribute not only through enhanced adaptation capabilities potentiated by their genetic diversity, but harbor a capability to escape from a restrictive or hostile microenvironment.